{
  "variants": [
    {
      "gene": "SNCA",
      "protein_change": "E46K",
      "variant_string_id": "SNCA E46K",
      "functional_evidence_aim": "pathogenic",
      "steps": {
        "step_1": {
          "judgment": "Yes",
          "details": "The study explicitly links α-synuclein (αS) aggregation to Lewy body formation, a hallmark of autosomal dominant LBD."
        },
        "step_2": {
          "judgment": "Yes",
          "details": "Assays like thioflavin S, CD spectroscopy, and EM/AFM are standard for studying protein aggregation, directly relevant to the disease mechanism."
        },
        "step_3a": {
          "judgment": "Yes",
          "details": "Wild-type (WT) αS is used as a control, and the study mentions 'multiple replicates' for experimental validation."
        },
        "step_3c": {
          "judgment": "No",
          "details": "The study does not use known pathogenic or benign variants as controls, only WT αS."
        },
        "step_4a": {
          "judgment": "No",
          "details": "No statistical tests (p-values, effect sizes) are explicitly mentioned in the abstract."
        },
        "step_4b": {
          "judgment": "Yes",
          "details": "Only 1 benign/pathogenic variant control (WT) is used, which is <10."
        },
        "final_evidence_strength": "PS3_supporting"
      }
    },
    {
      "gene": "SNCA",
      "protein_change": "A30P",
      "variant_string_id": "SNCA A30P",
      "functional_evidence_aim": "pathogenic",
      "steps": {
        "step_1": {
          "judgment": "Yes",
          "details": "The study explicitly links αS aggregation to Lewy body formation, a hallmark of autosomal dominant LBD."
        },
        "step_2": {
          "judgment": "Yes",
          "details": "Assays like thioflavin S, CD spectroscopy, and EM/AFM are standard for studying protein aggregation, directly relevant to the disease mechanism."
        },
        "step_3a": {
          "judgment": "Yes",
          "details": "Wild-type (WT) αS is used as a control, and the study mentions 'multiple replicates' for experimental validation."
        },
        "step_3c": {
          "judgment": "No",
          "details": "The study does not use known pathogenic or benign variants as controls, only WT αS."
        },
        "step_4a": {
          "judgment": "No",
          "details": "No statistical tests (p-values, effect sizes) are explicitly mentioned in the abstract."
        },
        "step_4b": {
          "judgment": "Yes",
          "details": "Only 1 benign/pathogenic variant control (WT) is used, which is <10."
        },
        "final_evidence_strength": "PS3_supporting"
      }
    },
    {
      "gene": "SNCA",
      "protein_change": "A53T",
      "variant_string_id": "SNCA A53T",
      "functional_evidence_aim": "pathogenic",
      "steps": {
        "step_1": {
          "judgment": "Yes",
          "details": "The study explicitly links αS aggregation to Lewy body formation, a hallmark of autosomal dominant LBD."
        },
        "step_2": {
          "judgment": "Yes",
          "details": "Assays like thioflavin S, CD spectroscopy, and EM/AFM are standard for studying protein aggregation, directly relevant to the disease mechanism."
        },
        "step_3a": {
          "judgment": "Yes",
          "details": "Wild-type (WT) αS is used as a control, and the study mentions 'multiple replicates' for experimental validation."
        },
        "step_3c": {
          "judgment": "No",
          "details": "The study does not use known pathogenic or benign variants as controls, only WT αS."
        },
        "step_4a": {
          "judgment": "No",
          "details": "No statistical tests (p-values, effect sizes) are explicitly mentioned in the abstract."
        },
        "step_4b": {
          "judgment": "Yes",
          "details": "Only 1 benign/pathogenic variant control (WT) is used, which is <10."
        },
        "final_evidence_strength": "PS3_supporting"
      }
    },
    {
      "gene": "SNCA",
      "protein_change": "A30P/A53T",
      "variant_string_id": "SNCA A30P/A53T",
      "functional_evidence_aim": "pathogenic",
      "steps": {
        "step_1": {
          "judgment": "Yes",
          "details": "The study explicitly links αS aggregation to Lewy body formation, a hallmark of autosomal dominant LBD."
        },
        "step_2": {
          "judgment": "Yes",
          "details": "Assays like thioflavin S, CD spectroscopy, and EM/AFM are standard for studying protein aggregation, directly relevant to the disease mechanism."
        },
        "step_3a": {
          "judgment": "Yes",
          "details": "Wild-type (WT) αS is used as a control, and the study mentions 'multiple replicates' for experimental validation."
        },
        "step_3c": {
          "judgment": "No",
          "details": "The study does not use known pathogenic or benign variants as controls, only WT αS."
        },
        "step_4a": {
          "judgment": "No",
          "details": "No statistical tests (p-values, effect sizes) are explicitly mentioned in the abstract."
        },
        "step_4b": {
          "judgment": "Yes",
          "details": "Only 1 benign/pathogenic variant control (WT) is used, which is <10."
        },
        "final_evidence_strength": "PS3_supporting"
      }
    }
  ]
}